JP2023522883A5 - - Google Patents
Info
- Publication number
- JP2023522883A5 JP2023522883A5 JP2022562939A JP2022562939A JP2023522883A5 JP 2023522883 A5 JP2023522883 A5 JP 2023522883A5 JP 2022562939 A JP2022562939 A JP 2022562939A JP 2022562939 A JP2022562939 A JP 2022562939A JP 2023522883 A5 JP2023522883 A5 JP 2023522883A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- virus vector
- nucleic acid
- raav virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063010179P | 2020-04-15 | 2020-04-15 | |
| US63/010,179 | 2020-04-15 | ||
| PCT/US2021/027266 WO2021211700A1 (en) | 2020-04-15 | 2021-04-14 | Compositions and methods for treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522883A JP2023522883A (ja) | 2023-06-01 |
| JP2023522883A5 true JP2023522883A5 (https=) | 2024-04-15 |
Family
ID=78081428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562939A Pending JP2023522883A (ja) | 2020-04-15 | 2021-04-14 | 神経学的障害を処置するための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11753655B2 (https=) |
| EP (1) | EP4135661A4 (https=) |
| JP (1) | JP2023522883A (https=) |
| KR (1) | KR20230004617A (https=) |
| CN (1) | CN115715185A (https=) |
| AU (1) | AU2021255934A1 (https=) |
| CA (1) | CA3175406A1 (https=) |
| IL (1) | IL296857A (https=) |
| WO (1) | WO2021211700A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11753655B2 (en) * | 2020-04-15 | 2023-09-12 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treatment of neurological disorders |
| WO2023102518A1 (en) * | 2021-12-03 | 2023-06-08 | The Board Of Regents Of The University Of Texas System | Gnao1 gene therapy vectors and uses thereof |
| EP4713462A1 (en) * | 2023-05-18 | 2026-03-25 | Gencorrex Therapies Inc. | Solute carrier family 6 member 8 vectors and methods for use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8676330B2 (en) * | 2009-03-20 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders |
| US20070292922A1 (en) * | 2006-03-31 | 2007-12-20 | Cell Genesys, Inc. | Regulated expression of recombinant proteins from adeno-associated viral vectors |
| EP2771367B1 (en) * | 2011-10-25 | 2017-12-06 | Indiana University Research and Technology Corporation | Gigaxonin fusion protein and methods for treating giant axonal neuropathy |
| CN105745326A (zh) * | 2013-10-24 | 2016-07-06 | 优尼科Ip有限公司 | 用于基因治疗神经疾病的aav-5假型载体 |
| US10016514B2 (en) * | 2015-05-15 | 2018-07-10 | New Hope Research Foundation | Polynucleotides, vectors and methods for insertion and expression of transgenes |
| AU2016324317A1 (en) * | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| WO2018109207A1 (en) * | 2016-12-16 | 2018-06-21 | Uniqure Ip B.V. | Immunoadsorption |
| IL280300B2 (en) | 2018-08-10 | 2025-06-01 | Univ North Carolina Chapel Hill | Optimized cln7 genes and expression cassettes and their use |
| US11753655B2 (en) * | 2020-04-15 | 2023-09-12 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treatment of neurological disorders |
-
2021
- 2021-04-14 US US17/230,484 patent/US11753655B2/en active Active
- 2021-04-14 IL IL296857A patent/IL296857A/en unknown
- 2021-04-14 AU AU2021255934A patent/AU2021255934A1/en active Pending
- 2021-04-14 JP JP2022562939A patent/JP2023522883A/ja active Pending
- 2021-04-14 KR KR1020227039686A patent/KR20230004617A/ko active Pending
- 2021-04-14 CN CN202180042428.0A patent/CN115715185A/zh active Pending
- 2021-04-14 WO PCT/US2021/027266 patent/WO2021211700A1/en not_active Ceased
- 2021-04-14 EP EP21789434.4A patent/EP4135661A4/en active Pending
- 2021-04-14 CA CA3175406A patent/CA3175406A1/en active Pending
-
2023
- 2023-07-19 US US18/355,380 patent/US12534741B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522883A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| JP2024514956A5 (https=) | ||
| JP2023002680A5 (https=) | ||
| JP2021121638A5 (https=) | ||
| JP2020510428A5 (https=) | ||
| Federici et al. | Gene‐based treatment of motor neuron diseases | |
| JP2022519623A5 (https=) | ||
| FI4206216T3 (fi) | Adenoassosioituneen viruksen kapsidimuunnoksia ja menetelmiä niiden käyttämiseksi | |
| JP2021522842A5 (https=) | ||
| JP2021520203A5 (https=) | ||
| JP2020513811A5 (https=) | ||
| JP2022520232A5 (https=) | ||
| WO2023060269A4 (en) | Recombinant adeno-associated viruses for targeted delivery | |
| JP2023535576A5 (https=) | ||
| JP2024523707A5 (https=) | ||
| JP2024513949A5 (https=) | ||
| JP2022530833A5 (https=) | ||
| JP2022531809A5 (https=) | ||
| JP2022522776A5 (https=) | ||
| JP2024515459A5 (https=) | ||
| US20220062325A1 (en) | Enhancing aav-mediated transduction of ocular tissues with hyaluronic acid | |
| JP2024520815A5 (https=) | ||
| CN114276419B (zh) | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 | |
| JP2024546103A5 (https=) |